ArticleThe oncologist2024

Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments.

Matthew Anaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.